MGI on LinkedIn: #rnaseq #genomics #sequencing (2024)

Established in 2016, MGI has grown into a global leader in life sciences, serving a network of over 2800 clients worldwide. At MGI, our pursuit of boundless innovation propels us to unravel life's mysteries.Experience our journey, expertise, and commitment to shaping the future of life sciences in our latest corporate video. Join us in our mission to drive global impact and spearhead #innovation!#Biotech #LifeScience #Sequencing #Genomics #CorporateVideo

124

Exciting proof of the outstanding performance of Stereo-seq technology.💡 A cutting-edge approach to classify cell types at a subcellular level, integrating transcriptomic data with spatial context. 🧪🔬 This breakthrough enhances cell classification in human kidney tissue and identifies rare immune cells in mouse models. 🐭👩🔬 Check out the full paper here: https://lnkd.in/eqVyMPcR#SpatialTranscriptomics #CellClassification #SciencePublication #Nature #Stereoseq

15

Dive into the world of multi-omics with DNBSEQ-G400RS FluoXpert! 🧬✨At 2024, MGI launched the innovative DNBSEQ-G400RS FluoXpert ("FluoXpert") in the APAC region and opened early access to the platform. Combining MGI's #DNBSEQ sequencing technology with advanced multiplex immunofluorescence (#mIF) staining technology, the FluoXpert challenges conventions and pushes the limits of life science and technology as a multi-functional sequencer that is compatible with in vivo spatial protein detection.Read the full press release at: https://lnkd.in/g7GSuRNW#MedlabAsia2024 #MultiOmics #Thailand #Biotechnology #SpatialOmics

70

🤝 🤝 We are thrilled to share that MGI has entered into a transformative collaboration with Predica Diagnostics BV to innovate in oncology diagnostics.Predica Diagnostics, renowned for its pioneering work in oncology, will harness the power of MGI's cost-effective Next-generation sequencing platforms to develop targeted RNA sequencing tests. These tests aim to revolutionize cancer detection by enabling early diagnosis and personalized treatment strategies.🌟Together, we aim to deliver rapid, accurate, and affordable solutions that empower healthcare providers to enhance patient care through advanced molecular diagnostics. 🚀 Read the press release: https://lnkd.in/gYqi7XW9#MolecularDiagnostics #PrecisionMedicine #CancerDetection #RNAsequencing #NGS #LifeSciences #oncology

30

2 Comments

Awesome news!!! Can't wait for the new journey!

4

Thrilled to unveil the very first DNBSEQ-G99 installation in the Middle East region with our partner Genetics Company for Biotechnology! 🎉 🎈 GenoDiscovery “JoClone biotek", the Laboratory division of Genetics Company has incorporated the DNBSEQ-G99 to offer unique in-house services in Jordan which includes Whole Genome Sequencing, Microbial Research, and Whole Exome Sequencing for Rare Human Genetic Diseases, in addition to NIPT panels. Moreover,the facility will also offer training courses to researchers, students, and lab technicians on various sequencing applications.Get ready to embark on a journey of innovation and discovery with G99! 🌟🔬#Biotechnology #MiddleEast #Jordan

181

7 Comments

One day to go! We will be attending the 7th NHS Oncology Conference: Exploring innovation and best practice on July 10 in UK!🎉Convenzis GroupJoin us at our booth to explore how our cutting-edge technologies are revolutionizing oncology research and patient care. See you there! 👋 #NHSOncologyConference #InnovationInOncology #MGIatNHS2024 #Convenzis

15

1 Comment

⏰ 1 day to go! ⏰ Join us tomorrow at Booth H6.C30 at Queen Sirikit National Convention Center to explore the potential of genomics!

8

Exciting news! MGI today has formally partnered with The University of Queensland's Center for Environmental and Agricultural Solutions to Antimicrobial Resistance (ARC Training Centre for Environmental and Agricultural Solutions to Antimicrobial Resistance), backed by the Australian Research Council. By harnessing the cutting-edge DNBSEQ™ technology, MGI aims to empower CEAStAR in addressing the urgent worldwide challenge of antimicrobial-resistant infections impacting human health, agriculture, and the environment. 🌿💊 Read the full article on MGI page: https://lnkd.in/gbQ2qMYF#CEAStAR #Research #AntimicrobialResistance #Australia

34

Experience MGI stLFR technique power through the study on Lablab purpureus genome in Thailand!Lablab (Lablab purpureus (L.) Sweet), an underutilized tropical legume crop, plays a crucial role in global food and nutritional security.A recent study published on Frontiers in Plant Science, conducted by researchers from BIOTEC-NSTDA and Kasetsart University, successfully realized a high-quality chromosome-scale reference assembly of the Lablab purpureus genome and revealed significant amplification of genes related to biotic and abiotic stress responses, which provides an invaluable genomic resource for lablab genetic improvement and future comparative genomics studies among legume species.The team sequenced and assembled the draft genome of L. purpureus accession PK2022T020 using the single tube long fragment read (stLFR) technique, where MGIEasy stLFR Library Prep Kit was utilized to construct the stLFR sequencing library. Additionally, MGIEasy RNA Library Prep Kit v3.0 was used to construct RNA libraries for transcriptome sequencing. Both stLFR and RNA libraries were sequenced on the DNBSEQ-G400RS platform, contributing to the study's success and subsequent insights gained.At MGI, we're dedicated to empowering scientific discoveries and breakthroughs. Take strides with us on an unstoppable path toward innovation!Read the full paper on Frontiers: https://lnkd.in/gtk8NNURLearn more about MGIEasy stLFR Library Prep Kit: https://lnkd.in/gfauPBth#PlantScience #stLFR #Research#ScientificDiscovery

31